These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19141125)

  • 1. Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation.
    Wang Z; Shi BY; Qian YY; Cai M; Wang Q
    Clin Exp Immunol; 2009 Mar; 155(3):496-503. PubMed ID: 19141125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD25 appears non essential for human peripheral T(reg) maintenance in vivo.
    de Goër de Herve MG; Gonzales E; Hendel-Chavez H; Décline JL; Mourier O; Abbed K; Jacquemin E; Taoufik Y
    PLoS One; 2010 Jul; 5(7):e11784. PubMed ID: 20689592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
    Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation.
    Vondran FW; Timrott K; Tross J; Kollrich S; Schwarz A; Lehner F; Klempnauer J; Becker T; Schwinzer R
    Transpl Int; 2010 May; 23(5):514-23. PubMed ID: 19951265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA.
    Engela AU; Hoogduijn MJ; Boer K; Litjens NH; Betjes MG; Weimar W; Baan CC
    Clin Exp Immunol; 2013 Aug; 173(2):343-54. PubMed ID: 23607314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
    Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
    Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report.
    Zhao T; Yang C; Xue Y; Qiu YY; Hu L; Qiu Y; Wang X; Yang B; Rong R; Xu M; Zhu T
    Transplant Proc; 2012 Jan; 44(1):175-8. PubMed ID: 22310608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H.
    Bloom DD; Chang Z; Fechner JH; Dar W; Polster SP; Pascual J; Turka LA; Knechtle SJ
    Am J Transplant; 2008 Apr; 8(4):793-802. PubMed ID: 18261176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the IL-15 pathway in anti-CD25 mAb treated renal allograft recipients.
    Baan CC; van Riemsdijk-Overbeeke IC; Boelaars-van Haperen MJ; IJzermans JM; Weimar W
    Transpl Immunol; 2002 Jun; 10(1):81-7. PubMed ID: 12182469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer.
    Okita R; Yamaguchi Y; Ohara M; Hironaka K; Okawaki M; Nagamine I; Ikeda T; Emi A; Hihara J; Okada M
    Int J Oncol; 2009 Feb; 34(2):563-72. PubMed ID: 19148493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulatory T cells in kidney transplant recipients].
    Libetta C; Portalupi V; Margiotta E; Sepe V; Canevari M; Meloni F; Morosini M; Dal Canton A
    G Ital Nefrol; 2009; 26 Suppl 45():S54-7. PubMed ID: 19382095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipients.
    Hoerning A; Köhler S; Jun C; Lu J; Fu J; Tebbe B; Dolff S; Feldkamp T; Kribben A; Hoyer PF; Witzke O
    Clin Exp Immunol; 2012 May; 168(2):251-9. PubMed ID: 22471287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody.
    Vignali D; Gürth CM; Pellegrini S; Sordi V; Sizzano F; Piemonti L; Monti P
    Transplantation; 2016 Sep; 100(9):1853-61. PubMed ID: 27306531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.
    Kamikozuru K; Fukunaga K; Hirota S; Hida N; Ohda Y; Yoshida K; Yokoyama Y; Tozawa K; Kawa K; Iimuro M; Nagase K; Saniabadi AR; Nakamura S; Miwa H; Matsumoto T
    Clin Exp Immunol; 2009 May; 156(2):320-7. PubMed ID: 19292766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
    Bayer AL; Yu A; Malek TR
    J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.
    Bluestone JA; Liu W; Yabu JM; Laszik ZG; Putnam A; Belingheri M; Gross DM; Townsend RM; Vincenti F
    Am J Transplant; 2008 Oct; 8(10):2086-96. PubMed ID: 18828769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selective depletion of CD4(+)CD25(+) regulatory T-cells from PBMC using anti-tac-SAP.
    Akbari A; Rezaei A
    J Immunotoxicol; 2012; 9(4):368-73. PubMed ID: 22506556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion.
    Okawaki M; Yamaguchi Y; Okita R; Ohara M; Okada M
    Hiroshima J Med Sci; 2008 Mar; 57(1):37-46. PubMed ID: 18578365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients.
    Vafadari R; Quaedackers ME; Kho MM; Mol WM; Chan G; Weimar W; Baan CC
    Transplantation; 2012 Sep; 94(5):465-72. PubMed ID: 22960764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.